ArticleBone marrow transplantation2024

Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease.

Lennart Philippen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.